Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. BSX’s Mahoney details outlook on up-and-coming businesses, including renal denervation and ICDs
Boston Scientific CEO Michael Mahoney details the med-tech titan’s 2012-2013 development and regulatory approval timelines for its up-and-coming business regions, including for its newly acquired Cameron Health subcutaneous implantable defibrillators and its bronchial thermoplasty business.
2. Weight loss: EndoBarrier effective against obesity and diabetes
GI Dynamics’ EndoBarrier implant proved more effective in treating both obesity and Type II diabetes in as little as 6 months of use than diet alone.
1. FDA: Possible selection bias issues ‘confound’ Edwards’ Sapien study
FDA reviewers want an agency panel to consider whether a study of Edwards Lifesciences’ Sapien heart valve was flawed in the way it selected and categorized higher-risk patients.